Tweet
J Med Virol
. 2020 Jul 9.
doi: 10.1002/jmv.26281. Online ahead of print.
Early-stage Predictors of the Acute Phase Duration in Uncomplicated COVID-19 Pneumonia
Claudio Carallo 1 2 , Fabiola Pugliese 2 3 , Cesare Tripolino 2 4 , Lorenza Lenzi 2 3 , Chiara Oliveri 2 3 , Giada Fasani 2 5 , Giovanni Maria Guarrera 2 6 , Walter Spagnolli 2 5 , Susanna Cozzio 2 3
Affiliations
- PMID: 32644215
- DOI: 10.1002/jmv.26281
Abstract
Objective: In this study, we aimed to highlight the common early-stage clinical and laboratory variables independently related to the acute phase duration in patients with uncomplicated coronavirus disease (COVID-19) pneumonia.
Methods: In hospitalized patients, the acute phase disease duration was followed using the Brescia-COVID respiratory severity scale (BCRSS). Noninvasive ventilation was administered based on clinical judgment. Patients requiring oropharyngeal intubation were excluded from the study. For parameters to be measured at the hospital entrance, age, clinical history, National Early Warning Score2 (NEWS2, a multiparametric score system), partial pressure of oxygen in arterial blood/fraction of inspired oxygen (P/F ratio), C-reactive protein, and blood cell count were selected.
Results: In 64 patients, age (direct relationship), P/F, and platelet number (inverse relationship) independently accounted for 43% of the acute phase duration of the disease (p<0.001).
Conclusions: For the first time, the present results revealed that the acute phase duration of non-complicated pneumonia, resulting from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is independently predicted from a patient's age, as well as based on the hospital entrance values of P/F ratio and peripheral blood platelet count. This article is protected by copyright. All rights reserved.
Keywords: COVID-19 pneumonia; SARS-CoV-2; disease duration; hospital resources; hospital stay; in-hospital.